TUDCA (Tauroursodeoxycholic Acid) is a water-soluble bile acid that occurs naturally in the body. It is a conjugate of taurine and ursodeoxycholic acid (UDCA) — a compound with a long history of use in supporting liver health.

TUDCA has been extensively studied for its role in normal bile flow and liver cell function, and is of growing interest in the fields of sports science and longevity research. OHC Longevity TUDCA delivers 500mg of Tauroursodeoxycholic Acid per vegan capsule, third-party tested for identity and potency.

Each bottle is a 2-month supply.

QUALITY YOU CAN VERIFYEvery batch of OHC Longevity TUDCA is independently tested by a third-party laboratory to verify ingredient identity, purity, and potency. We make our certificates of analysis available so you can see exactly what's in every capsule. [See the TUDCA Certificate of Analysis →]

Take 1 capsule with or without food daily, or as directed by your healthcare practitioner.

Store below 25°C in a cool, dark place. Keep out of reach of children.

Serving size: 1 capsule (500mg) |

Servings per bottle: 60 Active ingredient: 500mg Tauroursodeoxycholic Acid per serve Other ingredients: Hydroxypropyl Methyl Cellulose (Vegan Capsule)

Formulated Supplementary Sports Food

We ship Australia-wide and internationally to New Zealand, the USA, Canada, the UK, and Ireland.

Orders placed before 1:30 PM (AEST) are processed and dispatched the same day, except during peak times such as new launches, major sales, or holidays when processing may take longer.

Delivery Timeframes

• Domestic (Australia): Standard shipping typically takes 2–8 business days.
  
• International: Standard shipping usually takes 7–30 business days, depending on your destination.
  

Once your order has been dispatched, you’ll receive an email with your tracking details. Shipping costs are calculated based on your location and the number of items in your order.

Free Shipping: Domestic orders over $150 AUD receive free standard shipping.

Please double-check your shipping address before completing your purchase, as we cannot make changes once an order has been shipped.

If your order arrives damaged, defective, or incorrect, we’ll happily replace it or issue a refund. Please contact us within 14 days of receiving your item to arrange this.

To be eligible, items must be unopened, unused, and in their original condition, accompanied by proof of purchase, and must comply with Australian Consumer Law.

We cover return shipping costs for faulty or incorrect orders. Once your return is received and inspected, refunds will be processed within 10 business days.

Always read the label and follow the directions for use. This product is a Formulated Supplementary Sports Food intended for use by healthy adults engaged in regular, strenuous physical activity. It is not intended to diagnose, treat, cure or prevent any disease or health condition. Not suitable for use by individuals under 18 years of age, or during pregnancy or breastfeeding. If you have a medical condition or are taking prescription medication, consult your healthcare professional before use. Individual results may vary. Keep out of reach of children.

Li J, Huang Z, Jin Y, Liang L, Li Y, Xu K, Zhou W, Li XNeuroprotective Effect of Tauroursodeoxycholic Acid (TUDCA) on In Vitro and In Vivo Models of Retinal Disorders: A Systematic Review.Curr Neuropharmacol.(2024)

Marciniak SJ, Chambers JE, Ron DPharmacological targeting of endoplasmic reticulum stress in disease.Nat Rev Drug Discov.(2022 Feb)

Kusaczuk MTauroursodeoxycholate-Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives.Cells.(2019 Nov 20)

Kim YH, Kim JH, Kim BG, Lee KL, Kim JW, Koh SJTauroursodeoxycholic acid attenuates colitis-associated colon cancer by inhibiting nuclear factor kappaB signaling.J Gastroenterol Hepatol.(2019 Mar)

Häussinger D, Kordes CMechanisms of Tauroursodeoxycholate-Mediated Hepatoprotection.Dig Dis.(2017)

Kars, Marleen et al. “Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.”Diabetesvol. 59,8 (2010): 1899-905. doi:10.2337/db10-0308 https://pubmed.ncbi.nlm.nih.gov/20522594/

Walsh, Lauren K et al. “Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load.”Clinical science (London, England : 1979)vol. 130,21 (2016): 1881-8. doi:10.1042/CS20160501
https://pubmed.ncbi.nlm.nih.gov/27503949/

Panella, C et al. “Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease?.”The Italian journal of gastroenterologyvol. 27,5 (1995): 256-8.
https://pubmed.ncbi.nlm.nih.gov/8541578/

Crosignani, A et al. “Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study.”Digestive diseases and sciencesvol. 41,4 (1996): 809-15. doi:10.1007/BF02213140
https://pubmed.ncbi.nlm.nih.gov/8674405/